| 1 |
27991698 | A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis. | 2017 May |
1 |
| 2 |
24100279 | An EGFR/CD13 bispecific fusion protein and its enediyne-energized analog show potent antitumor activity. | 2014 Jan |
1 |
| 3 |
23599760 | Small antibody fusion proteins with complementarity-determining regions and lidamycin for tumor targeting therapy. | 2013 Apr |
2 |
| 4 |
21416325 | Antitumor effects of an engineered and energized fusion protein consisting of an anti-CD20 scFv fragment and lidamycin. | 2011 Mar |
1 |
| 5 |
19635191 | [Construction of energized fusion protein consisting of epidermal growth factor receptor oligopeptide ligand and lidamycin and its antitumor activity]. | 2009 Jun |
1 |
| 6 |
19737585 | Binding capability of the enediyne-associated apoprotein to human tumors and constitution of a ligand oligopeptide-integrated protein. | 2009 Oct 26 |
1 |